Cite
HARVARD Citation
Reisner, A. et al. (2022). Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study. Experimental biology and medicine. 247 (2), pp. 145-151. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reisner, A. et al. (2022). Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study. Experimental biology and medicine. 247 (2), pp. 145-151. [Online].